European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

EMA Veterinary Medicines Info Day 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2026, 14:00 (CET) to 13 March 2026, 12:30 (CET)

Submitted by Anonymous (not verified) on 17 March 2026 - 16:53

EMA Veterinary Medicines Info Day 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2026, 14:00 (CET) to 13 March 2026, 12:30 (CET)

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 17 March 2026 - 16:42

Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Submitted by Anonymous (not verified) on 17 March 2026 - 16:29

Standard operating procedure for processing of requests for fee reduction falling under paragraph 5 of Article 6 of Regulation (EU) 2024/568

Human medicines European public assessment report (EPAR): Elfabrio, pegunigalsidase alfa, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 17 March 2026 - 16:10

Human medicines European public assessment report (EPAR): Elfabrio, pegunigalsidase alfa, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised

Referral: Melatomed and associated names, melatonin Article 29(4) referrals European Commission final decision, 11/12/2025, 18/02/2026, 17/03/2026

Submitted by Anonymous (not verified) on 17 March 2026 - 16:03

Referral: Melatomed and associated names, melatonin Article 29(4) referrals European Commission final decision, 11/12/2025, 18/02/2026, 17/03/2026

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 17 March 2026 - 15:52

Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 21, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More